Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
AY ›
AYRESVY
Trademark search for:
AYRESVY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-10-15 — Application filed
2021-10-19 — Application filed
2021-11-04 — Application filed
2022-06-29 — Assigned to examiner
2022-07-08 — Approved for pub - principal register
2022-07-15 — On hold - electronic record review required
2022-07-20 — Electronic record review complete
2022-08-02 — Attorney/dom.rep.revoked and/or appointed
2022-08-02 — Teas change of domestic representatives address
2022-08-02 — Teas change of correspondence received
2022-08-02 — Teas revoke/app/change addr of atty/dom rep received
2022-08-03 — Notification of notice of publication e-mailed
2022-08-11 — Teas post publication amendment received
2022-08-23 — Published for opposition
2022-08-23 — Official gazette publication confirmation e-mailed
2022-08-29 — Assigned to petition staff
2022-08-30 — Withdrawn from issue - petitions office request
2022-09-26 — Petition to director - change basis - granted
2022-09-26 — Attorney review/decision on amendment required
2022-09-28 — Attorney review completed
2022-10-12 — Notification of notice of publication e-mailed
2022-11-01 — Published for opposition
2022-11-01 — Official gazette publication confirmation e-mailed
2023-01-17 — Registered-principal register
2023-01-17 — Notice of registration confirmation emailed
2023-06-21 — Cancellation instituted no. 999999
2023-09-25 — Cancellation granted no. 999999
2023-11-21 — Cancellation terminated no. 999999
2023-11-21 — Cancelled section 18-total
2023-11-21 — Final status recorded
Owner Information
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA
Correspondent
CHRISTOPHER M HANES GLAXOSMITHKLINE BIOLOGICALS SA
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
